| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.8M | +22.1% |
| Cost of Revenue | $24.3M | +16.8% |
| Gross Profit | $10.5M | +36.5% |
| R&D Expense | $20K | +3.8% |
| SG&A Expense | $3.1M | +30.4% |
| Operating Income | -$7.6M | +4.9% |
| Interest Expense | $89K | +11.3% |
| Pre-tax Income | -$15.1M | +29.1% |
| Income Tax | $2.5M | -23.8% |
| Net Income | -$17.6M | +28.4% |
| EPS (Basic) | -$0.10 | +41.2% |
| EPS (Diluted) | -$0.10 | +41.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.2M | -19.8% |
| Accounts Receivable | $1.6M | -33.5% |
| Inventory | $3.4M | -20.6% |
| Current Assets | $8.1M | -22.2% |
| Total Assets | $36.4M | -15.3% |
| Current Liabilities | $8.3M | -26.8% |
| Total Liabilities | $44.7M | -19.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$337K | +67.9% |
| Capital Expenditures | $642K | -89.2% |
| Investing Cash Flow | -$749K | +88.0% |
| Financing Cash Flow | $545K | -85.0% |
| Free Cash Flow | -$979K | +86.0% |
| -$8.3M |
| +33.5% |